There is no denying the opportunities that the markets identified above present, but unfamiliar markets also present new challengess. Uknown and complex market access laws, digital censorship, physician's preferences and lack of trust all make it difficult to capitalize on this massive opportunity. The Pharmaceutical Growth Markets Report 2013-2014 aims to highlight the biggest opportunities globally and help you deal with the challenges of entering a new market. The report focuses on the countries offering the greatest opportunities: Mexico, Venezuela, Brazil, China, Thailand and Indonesia. It features contributions fromGSK, Pfizer, Bayer, Baxter, Shire and Novartis on their experiences entering these growth markets. Read more. (Source: eyeforpharma, 2013).
You are here: / Pharmaceutical Growth Markets 2013-2014